Skip to main content

Table 1 Characteristics of the 109 patients included in the analysis

From: Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

Age (Median, range) 59 30-79
  n (%)
Sex   
   Male 80 (73)
   Female 29 (27)
Nephrectomy   
   No 23 (21)
   Yes 86 (79)
Time between diagnosis and Sutent initiation   
   <= 12 months 53 (49)
   >12 months 54 (49)
   Unknown 2 (2)
Histology   
   Clear Cell 100 (91)
   Papillary 2 (2)
   Chromophobe 2 (2)
   Mixed 3 (3)
   Unclassified 2 (2)
Performance Status   
   0 59 (54)
   1 37 (34)
   2 13 (12)
Number of Metastatic sites   
   1 32 (29)
   >1 77 (71)
Site of metastatic disease   
   Lung 75 (69)
   Nodes 38 (35)
   Liver 10 (9)
   Renal bed 27 (25)
   Bones 39 (36)
   Brain 8 (7)
Hb   
   Median (range) 12.1 (8.6-17.9)
   <13 for Males, <11.5 for Females 57 (52)
   >= 13 for Males, >= 11.5 for Females 50 (46)
   Unknown 2 (2)
Ca   
   Median (range) 9.4 (1.0-12.1)
   <10 85 (78)
   >= 10 16 (15)
   Unknown 8 (7)
LDH   
   Normal 58 (53)
   Abnormal 38 (35)
   Unknown 13 (12)
ALP   
   Normal 74 (68)
   Abnormal 29 (27)
   Unknown 6 (5)